Connor, Clark & Lunn Investment Management (CC&L)’s Tandem Diabetes Care TNDM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.6M | Buy |
784,218
+139,230
| +22% | +$2.6M | 0.05% | 304 |
|
|
2025
Q1 | $12.4M | Buy |
644,988
+129,926
| +25% | +$2.49M | 0.05% | 281 |
|
|
2024
Q4 | $18.6M | Buy |
515,062
+242,965
| +89% | +$8.75M | 0.08% | 186 |
|
|
2024
Q3 | $11.5M | Buy |
272,097
+66,687
| +32% | +$2.83M | 0.06% | 247 |
|
|
2024
Q2 | $8.28M | Buy |
205,410
+34,043
| +20% | +$1.37M | 0.03% | 311 |
|
|
2024
Q1 | $6.07M | Sell |
171,367
-12,955
| -7% | -$459K | 0.03% | 393 |
|
|
2023
Q4 | $5.45M | Buy |
184,322
+58,981
| +47% | +$1.74M | 0.03% | 398 |
|
|
2023
Q3 | $2.6M | Sell |
125,341
-133,742
| -52% | -$2.78M | 0.01% | 545 |
|
|
2023
Q2 | $6.36M | Buy |
259,083
+11,815
| +5% | +$290K | 0.03% | 345 |
|
|
2023
Q1 | $10M | Buy |
247,268
+6,373
| +3% | +$259K | 0.05% | 251 |
|
|
2022
Q4 | $10.8M | Buy |
240,895
+226,171
| +1,536% | +$10.2M | 0.06% | 219 |
|
|
2022
Q3 | $705K | Buy |
+14,724
| New | +$705K | ﹤0.01% | 734 |
|
|
2021
Q4 | – | Sell |
-17,200
| Closed | -$2.05M | – | 1205 |
|
|
2021
Q3 | $2.05M | Buy |
+17,200
| New | +$2.05M | 0.01% | 517 |
|
|
2017
Q2 | – | Sell |
-1,430
| Closed | -$17K | – | 945 |
|
|
2017
Q1 | $17K | Hold |
1,430
| – | – | ﹤0.01% | 889 |
|
|
2016
Q4 | $31K | Sell |
1,430
-560
| -28% | -$12.1K | ﹤0.01% | 865 |
|
|
2016
Q3 | $152K | Buy |
+1,990
| New | +$152K | ﹤0.01% | 754 |
|